143 related articles for article (PubMed ID: 24456076)
1. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Samuels AL; Heng JY; Beesley AH; Kees UR
Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.
Beesley AH; Firth MJ; Ford J; Weller RE; Freitas JR; Perera KU; Kees UR
Br J Cancer; 2009 Jun; 100(12):1926-36. PubMed ID: 19436302
[TBL] [Abstract][Full Text] [Related]
3. JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
Delgado-Martin C; Meyer LK; Huang BJ; Shimano KA; Zinter MS; Nguyen JV; Smith GA; Taunton J; Winter SS; Roderick JR; Kelliher MA; Horton TM; Wood BL; Teachey DT; Hermiston ML
Leukemia; 2017 Dec; 31(12):2568-2576. PubMed ID: 28484265
[TBL] [Abstract][Full Text] [Related]
4. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
Li Y; Wei Y; Gu L
Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
[TBL] [Abstract][Full Text] [Related]
5. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
6. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.
Sung ES; Kim A; Park JS; Chung J; Kwon MH; Kim YS
Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
[TBL] [Abstract][Full Text] [Related]
10. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
[TBL] [Abstract][Full Text] [Related]
11. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK.
Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP
Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223
[TBL] [Abstract][Full Text] [Related]
12. Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
De Smedt R; Morscio J; Goossens S; Van Vlierberghe P
Blood Rev; 2019 Nov; 38():100591. PubMed ID: 31353059
[TBL] [Abstract][Full Text] [Related]
13. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression.
Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R
Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.
Follini E; Marchesini M; Roti G
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226848
[TBL] [Abstract][Full Text] [Related]
15. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
16. PI3K inhibition synergizes with glucocorticoids but antagonizes with methotrexate in T-cell acute lymphoblastic leukemia.
Silveira AB; Laranjeira AB; Rodrigues GO; Leal PC; Cardoso BA; Barata JT; Yunes RA; Zanchin NI; Brandalise SR; Yunes JA
Oncotarget; 2015 May; 6(15):13105-18. PubMed ID: 25869207
[TBL] [Abstract][Full Text] [Related]
17. Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Beesley AH; Palmer ML; Ford J; Weller RE; Cummings AJ; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Kees UR
Br J Cancer; 2006 Dec; 95(11):1537-44. PubMed ID: 17117183
[TBL] [Abstract][Full Text] [Related]
18. The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.
Schult C; Dahlhaus M; Glass A; Fischer K; Lange S; Freund M; Junghanss C
Anticancer Res; 2012 Feb; 32(2):463-74. PubMed ID: 22287733
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
Hulleman E; Kazemier KM; Holleman A; VanderWeele DJ; Rudin CM; Broekhuis MJ; Evans WE; Pieters R; Den Boer ML
Blood; 2009 Feb; 113(9):2014-21. PubMed ID: 18978206
[TBL] [Abstract][Full Text] [Related]
20. 2-Deoxy-D-glucose Restore Glucocorticoid Sensitivity in Acute Lymphoblastic Leukemia via Modification of N-Linked Glycosylation in an Oxygen Tension-Independent Manner.
Leni Z; Ćwiek P; Dimitrova V; Dulcey AS; Zamboni N; Simillion C; Rossi G; Leibundgut K; Arcaro A
Oxid Med Cell Longev; 2017; 2017():2487297. PubMed ID: 28814986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
